Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study

Inclusion Criteria: 1. Meets the diagnostic criteria for Carotid Atherosclerotic Plaque (CAP); 2. Meets the diagnostic criteria for dyslipidemia; 3. Meets the TCM syndrome differentiation criteria for Qi Stagnation and Blood Stasis pattern; 4. Aged 18-75 years, both sexes eligible; 5. Vital signs stable, conscious with normal communication ability; 6. Subject voluntarily participates and signs the informed consent form. Exclusion Criteria: 1. Patients with severe cardiovascular diseases, including acute myocardial infarction, unstable angina, NYHA Class II-IV heart failure, severe arrhythmias, congenital heart disease, or severe valvular heart disease; 2. Patients with poorly controlled hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure \>100 mmHg), severe cerebrovascular diseases, hemorrhagic or hematologic disorders, or malignant tumors; 3. Patients with hepatic dysfunction, defined as alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels exceeding twice the upper limit of normal, or renal insufficiency, defined as serum creatinine levels exceeding 1.5 times the upper limit of normal; 4. Patients with severe psychological disorders, intellectual disabilities, or language barriers; 5. Pregnant or lactating women; 6. Patients with known hypersensitivity to the investigational drug; 7. Patients concurrently participating in other clinical trials.